English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 904107      Online Users : 857
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5433


    Title: A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing
    Authors: Tsai, LR;Chen, MH;Chien, CT;Chen, MK;Lin, FS;Lin, KMC;Hwu, YK;Yang, CS;Lin, SY
    Contributors: Center for Nanomedicine Research;Division of Medical Engineering Research
    Abstract: Polyethylenimines (PEIs) are commonly used as a vehicle to deliver and protect siRNA, but the strong interaction still remains to be modulated for efficient siRNA release and silencing. Herein, a single-monomer derived linear-like PEI-co-PEG (LPEI-co-PEG, P2 ) was synthesized to substantially enhance the siRNA release, but not affect the efficiency of protection. The linear-like copolymer (P2 ) was only synthesized from a single-monomer by intensive synchrotron X-ray irradiation within 5?min, randomly producing both PEI and PEG segments. The counterpart vehicle, LPEI (P1 ), was also synthesized for comparison. We found that the P1 and P2 were able to prevent siRNA against enzymatic degradation. Most importantly, efficient siRNA release (52%) was only observed in the siRNA/P2 complexes and not in the siRNA/P1 complexes (<5%), suggesting that the PEG segment may modulate the interaction between siRNA and P2 segment. Specifically, P2 as well as P1 can emit photoluminescence; cancer cells exhibited a detectable photoluminescence after treatment with P1 and P2, indicative of their excellent transfection efficiency. Subsequently, the siGFP/P2 complexes knocked down GFP with excellent efficiency (75%) above the siGFP/P1 complexes (19%) and siGFP/Lipofectamine complexes (20%). Importantly, the siRNA with anti-VEGF function being associated with P2 have been demonstrated an excellent efficiency in the suppression of tumor growth.
    Date: 2011-05
    Relation: Biomaterials. 2011 May;32(14):3647-3653.
    Link to: http://dx.doi.org/10.1016/j.biomaterials.2011.01.059
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0142-9612&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000289020600012
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79952107509
    Appears in Collections:[楊重熙] 期刊論文
    [林淑宜] 期刊論文
    [林名釗] 期刊論文

    Files in This Item:

    File Description SizeFormat
    SCP79751535295.pdf1144KbAdobe PDF971View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback